Acrospire Investment Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,400
Closed -$44K 2542
2017
Q1
$44K Sell
2,400
-5,200
-68% -$95.3K 0.04% 1066
2016
Q4
$144K Buy
7,600
+3,900
+105% +$73.9K 0.06% 651
2016
Q3
$83K Sell
3,700
-1,000
-21% -$22.4K 0.06% 691
2016
Q2
$84K Buy
4,700
+2,000
+74% +$35.7K 0.06% 617
2016
Q1
$37K Buy
+2,700
New +$37K 0.03% 1184